Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study y

ANNALS OF ONCOLOGY

ELSEVIER

1. National Institute of Health and Medical Research (INSERM), AP-HP, University Paris Descartes
2. Canceropole Ile-de-France
3. Cancer Research for Personalized Medicine (CARPEM)
4. Paris Alliance of Cancer Research Institutes (PACRI)
5. LabEx Immunooncology
6. National Cancer Institute of France (INCa) [2012-218]
7. La Ligue Contre le Cancer
8. French Ministry of Health Program Hospitalier de Recherche Clinique 2009 (PHRC 2009) [AOM09 202]
9. HalioDx